AU Patent

AU2017200272A1 — Lipid compositions

Assigned to Arbutus Biopharma Corp · Expires 2017-02-02 · 9y expired

What this patent protects

LIPID COMPOSITIONS -n Abstract: Disclosed herein are lipid compositions comprising a cationic lipid of formula (I), a neutral lipid, a sterol and a 0 PEG or PEG-modified lipid, wherein formula (I) is (F). Also disclosed are methods of producing the cationic lipid of formula (I).

USPTO Abstract

LIPID COMPOSITIONS -n Abstract: Disclosed herein are lipid compositions comprising a cationic lipid of formula (I), a neutral lipid, a sterol and a 0 PEG or PEG-modified lipid, wherein formula (I) is (F). Also disclosed are methods of producing the cationic lipid of formula (I).

Drugs covered by this patent

Patent Metadata

Patent number
AU2017200272A1
Jurisdiction
AU
Classification
—
Expires
2017-02-02
Drug substance claim
No
Drug product claim
No
Assignee
Arbutus Biopharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.